Sun Pharma Introduces SUNday, Highlighting the Everyday Realities of Skin Cancer Care

Debuting in the official Big Game program, SUNday reflects Sun Pharma's commitment to listening to the skin cancer community and advancing care through partnership

MUMBAI, India and PRINCETON, N.J., Feb. 5, 2026 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and includes its subsidiaries and/or associated companies) today announced "SUNday," a skin cancer awareness campaign rooted in the idea that "Every Day is SUNday." The phrase reflects the belief that support, education, and connection should be available whenever they're needed—not just at certain moments in time—and underscores Sun Pharma's commitment to working alongside the skin cancer community to better support patients.

At the Big Game on Sunday, February 8, SUNday will appear in the official game program, using a moment of broad public attention to reinforce that skin cancer awareness and care extend far beyond designated awareness months or singular moments in time.

Skin cancer remains one of the most common cancers in the United States, with more than 3.5 million cases of skin cancer diagnosed each year.ⁱ For people impacted by skin cancer, care extends beyond appointments, with ongoing needs that can arise at any point along the journey.

Sun Pharma is helping usher in a new day for people living with skin cancer by advancing care across a broad spectrum of disease and supporting patients, caregivers, and healthcare professionals throughout the journey. Guided by the real needs of the skin cancer community, SUNday reflects an approach grounded in listening first, acting on what is learned, and doing what is right for patients. The effort is intended to support sustained awareness, encourage collaboration, and strengthen connections across the skin cancer community.

"What we consistently hear from patients and families is that skin cancer is part of their everyday reality. It doesn't end after an appointment or a diagnosis," said Frank Righetti, Vice President, Business Unit Head, Cutaneous Oncology, Sun Pharma. "That's why showing up for this community every day matters. SUNday reflects our commitment to helping people feel seen, supported, and connected throughout their care."

A centerpiece of the initiative is ItsSUNday.com, a resource designed to make information about skin cancer, prevention, and supportive care more accessible and easier to understand. The site will connect people to trusted advocacy organizations, like Skin Cancer Champions, The Skin Cancer Foundation, and AIM at Skin Cancer Foundation, and educational tools. Additional information and resources are available at ItsSUNday.com.

"Awareness, education, and partnership all play an important role in improving outcomes for those affected by skin cancer," said Emily S. Ruiz, MD, MPH, Co-Founder of Skin Cancer Champions. "Efforts like SUNday help keep attention on the ongoing needs of patients and caregivers, wherever they are in their journey."

SUNday reflects Sun Pharma's commitment to turning community insight into action through education, resources, and collaboration. Informed by ongoing input from patients, caregivers, clinicians, and advocacy partners, the initiative is designed to evolve over time and support continuity of care across the skin cancer journey.

About Sun Pharma in Cutaneous Oncology
For more than two decades, Sun Pharma has built on its established leadership in dermatology to advance care for people impacted by skin cancer. Working in collaboration with the broader skin cancer community, the company is focused on addressing needs across the disease continuum—from precancerous conditions to advanced skin cancers. With a dedicated cutaneous oncology team and a growing focus in specialty medicines, Sun Pharma applies scientific rigor, real-world insight, and partnership to support meaningful progress in care and improve continuity for patients, caregivers, and clinicians.

About Sun Pharmaceutical Industries Limited (CIN - L24230GJ1993PLC019050)
Sun Pharma is the world's leading specialty generics company with a presence in Innovative Medicines, Generics and Consumer Healthcare products. It is the largest pharmaceutical company in India and is a leading generic company in the U.S. as well as Global Emerging Markets. Sun's high growth Innovative Medicines portfolio spans innovative products in dermatology, ophthalmology, and onco-dermatology and accounts for about 20% of company sales. The company's vertically integrated operations deliver high-quality medicines, trusted by physicians and consumers in over 100 countries. Its manufacturing facilities are spread across six continents. Sun Pharma is proud of its multi-cultural workforce drawn from over 50 nations. For further information, please visit www.sunpharma.com and follow us on LinkedIn & X (formerly Twitter).

Disclaimer
Statements in this "Document" describing the Company's objectives, projections, estimates, expectations, plans or predictions or industry conditions or events may be "forward looking statements" within the meaning of applicable securities laws and regulations. Actual results, performance or achievements could differ materially from those expressed or implied. The Company undertakes no obligation to update or revise forward looking statements to reflect developments or circumstances that arise or to reflect the occurrence of unanticipated developments/circumstances after the date hereof.

MEDIA CONTACTS:
Jeremy Allen – Vice President, Corporate Affairs, Sun Pharma North America
Mobile: +1 640 230 1397
Email: [email protected]

Cherise Moore – Green Room Communications
Mobile: +1 301 267 4161
Email: [email protected]

© 2026 Sun Pharmaceutical Industries, Inc. All rights reserved.
NPM-US-ULX-0072 2/26

References:
ⁱ "FAQs about skin cancer and the dark side of the sun," Stony Brook Cancer Center, https://cancer.stonybrookmedicine.edu/melanoma-team/patients/FAQs_AboutSkinCancer.

SOURCE Sun Pharma